尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Divita Charles III, 首席执行官. Officer active across 1 company, notably Teladoc Health, Inc.. Aggregated, 14 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €193k. Activity tracked since 2 September 2026. The latest transaction was disclosed on 11 September 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
DIVITA CHARLES III is Directeur Général and is linked to Teladoc Health, Inc., where he holds the role of CHIEF EXECUTIVE OFFICER. The record shows 8 filings in total, with sampled filings dated from 2025-06-11 to 2026-06-12, and the most frequent transaction nature is Levée d'options.